Your browser doesn't support javascript.
loading
Stathmin is a potential therapeutic target but not a prognostic marker in melanoma: an immunohistochemical study of 323 melanocytic lesions.
Dundr, Pavel; Simon, Karol; Nemejcová, Kristýna; Bártu, Michaela; Tichá, Ivana; Michálková, Romana; Jaksa, Radek; Vecková, Zuzana; Kodet, Ondrej.
Afiliação
  • Dundr P; Institute of Pathology.
  • Simon K; Institute of Pathology.
  • Nemejcová K; Institute of Pathology.
  • Bártu M; Institute of Pathology.
  • Tichá I; Institute of Pathology.
  • Michálková R; Institute of Pathology.
  • Jaksa R; Institute of Pathology.
  • Vecková Z; Institute of Pathology.
  • Kodet O; Department of Dermatology and Venereology, First Faculty of Medicine, Charles University and General University Hospital in Prague.
Melanoma Res ; 29(2): 157-162, 2019 04.
Article em En | MEDLINE | ID: mdl-30422880
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Biomarcadores Tumorais / Estatmina / Melanócitos / Melanoma Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Melanoma Res Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Biomarcadores Tumorais / Estatmina / Melanócitos / Melanoma Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Melanoma Res Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article